Global Comparison of Erythrocyte EPA and DHA Concentrations in Pregnant Women

These findings highlight widespread insufficiency in maternal EPA+DHA status globally, with particularly severe deficiencies observed in Asia and parts of Europe. This study underscores the need for more research to ultimately define the optimal EPA+DHA concentrations during pregnancy using standardized blood biomarkers, along with pregnancy-specific reference ranges, to facilitate targeted nutritional strategies aimed at optimizing health outcomes for both mother and child. Future studies should focus on addressing data gaps, refining intake recommendations, and promoting accessible supplementation strategies.